Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum.

Pyoderma gangrenosum (PG) is a neutrophilic dermatosis that is challenging to diagnose and treat. Clinicians frequently use fast-acting corticosteroids, which are subsequently combined with slower-acting immunosuppressants to progressively taper the corticosteroid dosage. Current research is focused...

Full description

Bibliographic Details

Published in:	Advances in Skin & Wound Care Vol. 37; no. 5; pp. 276 - 280
Main Authors:	Michelucci, Alessandra, Manzo Margiotta, Flavia, Granieri, Giammarco, Salvia, Giorgia, Fidanzi, Cristian, Bevilacqua, Matteo, Panduri, Salvatore, Romanelli, Marco, Dini, Valentina
Format:	case study pictorial Journal Article
Published:	Lippincott Williams & Wilkins May2024
Online Access:	View this record in EBSCOhost